IDEX CORP (IEX) FY2026 Q3 P&L / Income Statement

Published · Updated Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Key Takeaways

  • Health & Science Technologies supplied $52.40 M of the $73.00 M sales rise, about 72% of it.
  • Fluid & Metering Technologies grew only 3.5%, adding $11.00 M against Health & Science's $52.40 M.
  • Restructuring charges hit $3.40 M, up from $0.10 M, partly for a facility closing in Health & Science.
  • Restructuring has cost IDEX $13.60 M in the first nine months of 2026 and $18.30 M in 2025.

The Unvarnished Truth

Health & Science carried the growth as a facility there nears closure

IDEX's sales rose $73.00 M, and Health & Science Technologies supplied $52.40 M of that, about 72%. Its sales rose 14% from a year earlier, the fastest of the three segments. The same segment is where the company plans to close a facility. The filing says this quarter's restructuring expenses were $3.40 M, against $0.10 M a year earlier, and that they were mostly severance tied to employee reductions, including the anticipated closure of a facility in that segment.

Why would the fastest-growing part of the company need job cuts? The filing does not say which products or customers are moving. What it does say is that the nine-month restructuring line also carried $4.80 M of asset impairments in Fluid & Metering Technologies, the segment whose sales grew only 3.5% this quarter. The two facts sit side by side in the filing, and the filing does not connect them. A reader cannot tell from the segment table alone whether the impairment and the closure are in the same place.

What it means: the segment that carries the growth is also the one with a closure the filing calls anticipated, and restructuring has been a yearly habit, at $18.30 M in the first nine months of 2025 and $13.60 M in 2026. Will the closure end the charges, or will the next quarter bring another restructuring line? If restructuring is a yearly habit, what would make this year's cost one-time?

2026-07-01 to 2026-09-30

Revenue by Business Segment (3 categories)

Swipe to see the full flow
IDEX CORP (IEX) FY2026 Q3 P&L / Income StatementIncome statement for 2026-07-01 through 2026-09-30. View: Business segment (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETHealth & Science TechnologiesFluid & Metering TechnologiesFire & Safety/Diversified ProductsNet salesGross profitCost of salesOperating incomeOperating expenses (calculated)Selling, general and administrative expensesRestructuring expenses and asset impairmentsIncome before income taxesOther income (expense), net (calculated)Net incomeProvision for income taxesNet salesNet sales$951.70 MGross profitGross profit$429.50 MOperating incomeOperating income$208.00 MIncome before income taxesPretax income$192.70 MNet incomeNet income$144.00 MHealth & Science TechnologiesHealth & Science Technologies$432.50 MOperating expenses (calculated)Operating expenses(calculated)$221.50 MProvision for income taxesProvision forincome taxes$48.70 MSelling, general and administrative expensesSelling, general andadministrative expenses$218.10 MOther income (expense), net (calculated)Other income,net (calculated)−$15.30 MCost of salesCost of sales$522.20 MFluid & Metering TechnologiesFluid & Metering Technologies$327.80 MRestructuring expenses and asset impairmentsRestructuring expensesand asset impairments$3.40 MFire & Safety/Diversified ProductsFire & Safety/Diversified Products$191.40 M
Chart details

IDEX CORP (IEX) FY2026 Q3 P&L / Income Statement

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales
951,700,000 US dollars
Cost of sales
522,200,000 US dollars
Gross profit
429,500,000 US dollars
Operating expenses (calculated)
221,500,000 US dollars
Operating income
208,000,000 US dollars
Other income (expense), net (calculated)
negative 15,300,000 US dollars
Income before income taxes
192,700,000 US dollars
Provision for income taxes
48,700,000 US dollars
Net income
144,000,000 US dollars
Health & Science Technologies
432,500,000 US dollars
Fluid & Metering Technologies
327,800,000 US dollars
Fire & Safety/Diversified Products
191,400,000 US dollars
Selling, general and administrative expenses
218,100,000 US dollars
Restructuring expenses and asset impairments
3,400,000 US dollars

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Of which attributable to IDEX CORP: $144.10 M; to noncontrolling interests: −$100.00 K.
IDEX CORP (IEX) FY2026 Q3 Revenue by Business Segment (3 categories) Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Intelligent Insights for Investors

Which of IDEX's businesses brings in the most sales?

Health & Science Technologies brought in 45% of sales this quarter, against 34% for Fluid & Metering Technologies, the next largest.

Intelligent Insights for Lenders

Which of IDEX's businesses generates the most sales per dollar of assets?

Fire & Safety/Diversified Products brought in $0.23 of revenue for each dollar of assets assigned to it at the end of the period, against $0.10 for Health & Science Technologies. That gap is a clue, not a verdict: the filing does not say how much of each segment's assets is acquired goodwill.

Intelligent Insights for Employees

Which of IDEX's businesses are being restructured?

The filing names a business: Health & Science Technologies, through the anticipated closure of a facility there. Restructuring charges were $3.40 M this quarter, against $0.10 M a year earlier, and the same MD&A section says they were mostly severance from employee reductions.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!